News Sentiment

EXOZ sentiment intelligence

eXoZymes, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 20 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 6.02 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 11

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-13.6% over one week, -23.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

eXoZymes (NASDAQ: EXOZ) raises $639K in unit sale with resettable warrants

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction -13.6% Price reacting lower
Trend fit Trend inactive -23.1% over four weeks
Fair value -49.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 12
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 11
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 6
Stock Titan 3
simplywall.st 3
TradingView 2
Simply Wall Street 1
FOX31 Denver 1
Investing.com UK 1
Nasdaq 1

Event Lens

What the news is about

Classified themes
Market update 10
Earnings 9
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-20 of 20
Stock Titan Direct company coverage

IZTC Stock Price, News & Analysis

Invizyne Technologies (IZTC), initially known for its cell-free, enzyme-based biomanufacturing technology, has since rebranded to eXoZymes Inc. and changed its NASDAQ ticker to EXOZ. The company focuses on developing AI-engineered enzymes ("exozymes") for sustainable production o

Tone
Positive 72/100
Event
Market update
Published
25 Apr 2025 23:51
Source
Stock Titan
Simply Wall Street Direct company coverage

eXoZymes, Inc. (EXOZ) Leadership & Management Team Analysis

This article provides an analysis of eXoZymes, Inc. (EXOZ) leadership and management team. It details the CEO's compensation and tenure, along with an overview of the management team and board of directors, including their average tenure and ownership stakes. The report also incl

Tone
Neutral 50/100
Event
Market update
Published
13 Feb 2025 18:08
Source
Simply Wall Street
FOX31 Denver Direct company coverage

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Invizyne Technologies, Inc. has rebranded to eXoZymes Inc., signaling a shift towards sustainable chemical production using AI-engineered enzymes. The company's NASDAQ ticker will change from IZTC to EXOZ. This move introduces "exozymes" as a new scientific concept, representing

Tone
Positive 74/100
Event
Market update
Published
12 Feb 2025 08:50
Source
FOX31 Denver
Investing.com UK Direct company coverage

Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ By Investing.com

Invizyne Technologies, Inc., a biomanufacturing firm specializing in enzyme-based systems, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective February 12, 2025, pending approvals. This change reflects its strategic fo

Tone
Neutral 50/100
Event
Market update
Published
10 Feb 2025 16:06
Source
Investing.com UK
Nasdaq Direct company coverage

Invizyne Technologies Announces Name Change To EXoZymes

Invizyne Technologies is changing its corporate name to eXoZymes, Inc., with trading under the new ticker symbol "EXOZ" expected to begin on February 12, 2025. The company specializes in cell-free, enzyme-based biomanufacturing systems for creating valuable biochemicals like Acti

Tone
Positive 63/100
Event
Market update
Published
10 Feb 2025 13:06
Source
Nasdaq
Investing.com Direct company coverage

Invizyne Technologies rebrands as eXoZymes with new ticker EXOZ

Invizyne Technologies, a company focused on enzyme-based biomanufacturing, has rebranded as eXoZymes, Inc. The company will trade under the new ticker symbol EXOZ, expected to be effective on February 12, 2025, pending approvals. This change reflects the company's strategic focus

Tone
Neutral 50/100
Event
Market update
Published
10 Feb 2025 11:05
Source
Investing.com
GlobeNewswire Direct company coverage

Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol

Invizyne Technologies, Inc. announced its corporate name change to eXoZymes, Inc. and applied for a new ticker symbol. The company expects to begin trading under the ticker symbol "EXOZ" on February 12, 2025, pending final approvals. Existing shareholders do not need to take any

Tone
Positive 65/100
Event
Guidance
Published
10 Feb 2025 11:00
Source
GlobeNewswire